MSI2 and non-small cell lung carcinoma: Notably, in non-small cell lung cancer (NSCLC) A549 cells that MSI2 was depleted in parallel (Figure 1C), no significant change of the survival and proliferation of A549 cells was detected upon depletion of MSI2 (Figures 1D,E).